Entry-level genetic report solutions from Roberto Grobman 2023
Genetic analysis services by Prof. Roberto Grobman today: Our Story: FullDNA has identified the need for creating a tool for healthcare professionals to access useful valuable genetic data from the big data pool of 21 million publications and growing daily roughly 2.5 million new publications every year. Our solution shows patients with a superior high accuracy rate what is written in their DNA, providing an excellent tool to understand what can happen and to act immediately to live longer and healthier. FullDNA provides an AI based customizable genetics prediction premium health tech platform to empower the capability of health professionals and institutions. FullDNA analyzes results from DNA sequencing Big Data using AI and complex algorithms to compares it with our own valuable extracted Database (updated daily) of more than 5,000 diseases and medical conditions, resulting in output of analysis & recommendation reports in various fields of medicine. Find even more details on Roberto Grobman CSO.
How will hospitals and doctors be able to use our DNA data? Imagine if our doctor and the hospitals treating us had additional insights into our individual response to medication. The opportunity to enhance our treatment plan could be really beneficial. In practice, right now, that could happen with a doctor or patient sharing their pharmacogenomics report. In order to be effective at scale we would need to see pharmacogenomics results and reports stored in a patient’s electronic health record.
Genetics report solutions with Prof. Roberto Grobman today: What are the benefits and risks of direct-to-consumer genetic testing? Direct-to-consumer genetic testing has both benefits and limitations, as they are somewhat different than those of genetic testing ordered by a healthcare provider. Benefits: Direct-to-consumer genetic testing promotes awareness of genetic diseases. It provides personalized information about your health, disease risk, and other traits. It may help you be more proactive about your health. It does not require approval from a healthcare provider or health insurance company.
Is all of this testing useful? For some people, the answer is clearly yes. When performed accurately, genetic tests can uncover a disease or a tendency to develop certain conditions, and it can lead to close relatives getting tested as well. Preventive measures or treatment can be lifesaving. Here are four examples (though there are many more). Hemochromatosis. This is a genetic condition in which too much iron is absorbed from the diet. The extra iron can harm important organs like the heart and liver. Once a person is diagnosed, phlebotomy (blood removal, similar to what happens during blood donation) and avoiding iron supplements can prevent serious complications such as diabetes and liver failure.
These tests can often allow doctors to see what’s going on that they may not be observing in a physical examination — things that don’t manifest in the body. But such hereditary and congenital diseases are rare. DNA is not destiny: People are complex, and there are many things that affect someone’s health and ability to be healthy — from environmental to genetic. Your DNA is saying who you are—– not what you can and can’t be. And that’s an important message. For example, Andrew Steel, a 400-metre runner and former Olympian, discovered that he didn’t have what is called ‘the sprint gene’, one of a pair of genes that almost all other Olympic sprinters have. Had he been told at an early age ‘you don’t have this gene, so you’ll never amount to anything in sport’, he may not have gone on to become an Olympic medal-winning runner. The example also demonstrates the importance of reputable advice on how to interpret the results of DNA health tests.
Our studies identified the relationship between Coronavirus and Genetics. We performed genetic analysis with more than 300 coronavirus patients in Brazil. We divided into 3 groups. A group of patients in the ICU in serious condition. A group with patients in the hospital but in a moderate state and a group with patients at home, with mild manifestation of the disease. We have a tool capable of predicting which individuals are at greater or lesser risk for the pandemic, and regarding vaccine risks. Find even more info on Roberto Grobman CTO.